You have 9 free searches left this month | for more free features.

Condition

Head and Neck Squamous Cell Carcinoma (1)

Non-Small Cell Lung Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

AbbVie (1)

Collaborator

Intervention

abbv-514 (1)

budigalimab (1)

pembrolizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

abbv-514

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC, Head and Neck Squamous Cell Carcinoma Trial in Israel, Japan, United States (ABBV-514, Pembrolizumab, Budigalimab)

Recruiting

Non-Small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma

ABBV-514
+2 more

Fullerton, California
+13 more

Jul 11, 2022